Overview

The Repatriation Medical Authority Instrument No. 59 of 2010 amends the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004 by addressing the issue of fibrosing interstitial lung disease among veterans. This legislative instrument was enacted to refine the understanding and assessment of conditions related to this disease, particularly in relation to smoking and its impact on the development of the condition. The objective of this amendment is to ensure that veterans who have developed fibrosing interstitial lung disease receive appropriate recognition and benefits. This legislative update was determined by the Repatriation Medical Authority under the authority granted by the Veterans' Entitlements Act 1986, with the aim of providing clarity and enhancing the eligibility criteria for those affected by this specific condition.

Scope and Application

The Repatriation Medical Authority Instrument No. 59 of 2010 amends Statement of Principles Instrument No. 35 of 2009 concerning fibrosing interstitial lung disease under the Veterans’ Entitlements Act 1986. This legislative instrument applies to veterans, service personnel, and their dependants who may be affected by fibrosing interstitial lung disease and seeks to address new factors related to smoking by adding definitions and considerations regarding 'pack-years of cigarettes, or the equivalent thereof in other tobacco products'. The scope of this legislation is focused on clarifying and expanding the understanding of the disease and its potential causes, particularly in the context of service-related conditions. The amendments introduced by this Instrument are intended to provide more comprehensive guidance and support to those affected by the condition, ensuring that their entitlements and claims are assessed with a full understanding of relevant factors. The amendments specify a date of effect in accordance with the Legislative Instruments Act 2003, indicating a clear timeline for the implementation of these changes. The Repatriation Medical Authority invited submissions from relevant organisations and experts but did not receive any during the investigation. This Instrument formalises the findings of the investigation into fibrosing interstitial lung disease, providing a definitive statement of principles for future assessments and claims.

Key Provisions

The main operative sections of this legislation concern the amendment of Statement of Principles Instrument No. 35 of 2009, relating to fibrosing interstitial lung disease, under the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004. Specifically, this Instrument introduces new factors 6(ua) and 6(ppa) concerning 'smoking', which are added to the list of contributing factors for this condition (section 2). Additionally, it inserts a definition for 'pack-years of cigarettes, or the equivalent thereof in other tobacco products' in clause 9 (section 2). The date of effect for these amendments is specified in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003 (section 3). The Repatriation Medical Authority (the Authority) has imposed several obligations and requirements on the parties and entities governed by this Act. The Authority must conduct an investigation into the specified condition, as evidenced by their advertisement in the Government Notices Gazette of 4 November 2009. During this investigation, the Authority solicited submissions from the Repatriation Commission, relevant organisations, and any individuals with expertise in the field, although no submissions were received for consideration (section 4). This Instrument finalises the investigation, ensuring that the newly amended Statement of Principles is officially adopted and documented (section 5). Furthermore, the Authority provides a list of references for any person or organisation to request, as specified in subsection 196E(1)(a) to (c) of the VEA (section 6). In terms of consequences for non-compliance, the legislation does not explicitly outline specific offences, penalties, or civil/criminal consequences for breach. However, the amendments to the Statement of Principles are likely to have significant implications for veterans' entitlements and military rehabilitation compensation claims related to fibrosing interstitial lung disease. Given the amendments' focus on the smoking factor, any future claims will need to take these new criteria into account. While no explicit penalties are mentioned, any failure to adhere to the updated conditions may result in complications or denial of claims, affecting the rights and benefits of veterans.